Four component meningococcal capsular Group B vaccine in preterm infants.
<p>The 4CMenB vaccine was introduced into the routine immunization schedule in the UK in September 2015 to protect against group B Neisseria meningitidis meningitis and septicemia. The vaccine is reactogenic in young infants, causing fever in 51-65% when co-administered with other vaccines [1,...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2017
|